NZ585217A - Fviii peptides and their use in tolerising haemophiliacs - Google Patents
Fviii peptides and their use in tolerising haemophiliacsInfo
- Publication number
- NZ585217A NZ585217A NZ585217A NZ58521708A NZ585217A NZ 585217 A NZ585217 A NZ 585217A NZ 585217 A NZ585217 A NZ 585217A NZ 58521708 A NZ58521708 A NZ 58521708A NZ 585217 A NZ585217 A NZ 585217A
- Authority
- NZ
- New Zealand
- Prior art keywords
- fviii peptides
- peptide
- peptides
- tolerising
- haemophiliacs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0723712.6A GB0723712D0 (en) | 2007-12-04 | 2007-12-04 | Peptides |
| PCT/GB2008/003996 WO2009071886A1 (en) | 2007-12-04 | 2008-12-03 | Fviii peptides and their use in tolerising haemophiliacs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ585217A true NZ585217A (en) | 2012-11-30 |
Family
ID=38982965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ585217A NZ585217A (en) | 2007-12-04 | 2008-12-03 | Fviii peptides and their use in tolerising haemophiliacs |
Country Status (25)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2353347T3 (es) | 2000-08-21 | 2011-03-01 | Apitope Technology (Bristol) Limited | Péptido. |
| GB0801513D0 (en) * | 2008-01-28 | 2008-03-05 | Circassia Ltd | Peptides from factor VIII |
| SI2300497T1 (sl) * | 2008-06-24 | 2013-02-28 | Octapharma Ag | Postopek za äťiĺˇäťenje koagulacijskega faktorja viii |
| GB0908515D0 (en) * | 2009-05-18 | 2009-06-24 | Apitope Technology Bristol Ltd | Peptide |
| CA2765657A1 (en) * | 2009-06-16 | 2010-12-23 | Tokai University | Anti-gram-negative bacteria agent |
| CN104926947A (zh) | 2010-10-27 | 2015-09-23 | 巴克斯特国际公司 | 用于免疫耐受性诱导和免疫诊断的fviii肽 |
| CA2863329C (en) | 2012-01-12 | 2023-01-03 | Biogen Idec Ma Inc. | Methods of reducing immunogenicity against factor viii in individuals undergoing factor viii therapy |
| EA036483B1 (ru) * | 2012-11-12 | 2020-11-16 | Эпитоп Интернэшнл Нв | Пептиды, способные индуцировать толерантность к рекомбинантному fviii, содержащая их композиция, их применение и способ лечения гемофилии |
| GB201314052D0 (en) | 2013-08-06 | 2013-09-18 | Apitope Int Nv | Peptides |
| CA3007262A1 (en) | 2015-12-03 | 2017-06-08 | Lucas James Thompson | Modified chimeric receptors and related compositions and methods |
| KR20190091292A (ko) | 2016-12-02 | 2019-08-05 | 바이오버라티브 테라퓨틱스 인크. | 응고 인자에 대한 면역 내성 유도 방법 |
| US12077607B2 (en) * | 2021-09-23 | 2024-09-03 | University Of Utah Research Foundation | Functional and therapeutic effects of PAR4 cleavage by cathepsin G |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5930890A (en) * | 1989-06-20 | 1991-01-08 | Scripps Clinic And Research Foundation | The phospholipid binding domain of factor viii |
| BR9806793A (pt) * | 1997-01-22 | 2000-05-16 | Univ Texas | Processos e composições de fator tissular para coagulação e tratamento de tumores. |
| ES2353347T3 (es) * | 2000-08-21 | 2011-03-01 | Apitope Technology (Bristol) Limited | Péptido. |
| WO2002060917A2 (en) * | 2000-12-01 | 2002-08-08 | Regents Of The University Of Minnesota | Method to treat hemophilia |
| HUP0303171A2 (hu) * | 2001-02-19 | 2003-12-29 | Merck Patent Gmbh | Csökkentett immunogenitású mesterséges fehérjék |
| AU2002312660A1 (en) * | 2001-05-31 | 2002-12-16 | D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven | Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools |
| AU2003232482A1 (en) * | 2002-04-18 | 2003-10-27 | Merck Patent Gmbh | Modified factor viii |
| AU2005211725B2 (en) * | 2004-02-09 | 2010-07-15 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| WO2006003183A1 (de) | 2004-07-02 | 2006-01-12 | Alois Jungbauer | Peptide zur blockierung von fviii-inhibitoren |
| IL229645A0 (en) * | 2013-11-26 | 2014-03-31 | Omrix Biopharmaceuticals Ltd | A dry bandage containing thrombin and pectin |
-
2007
- 2007-12-04 GB GBGB0723712.6A patent/GB0723712D0/en not_active Ceased
-
2008
- 2008-03-12 UA UAA201008194A patent/UA101003C2/uk unknown
- 2008-12-03 US US12/746,141 patent/US8445448B2/en not_active Expired - Fee Related
- 2008-12-03 CN CN201310392152.6A patent/CN103709234B/zh not_active Expired - Fee Related
- 2008-12-03 SI SI200831186T patent/SI2227488T1/sl unknown
- 2008-12-03 ES ES08855772.3T patent/ES2458315T7/es active Active
- 2008-12-03 AU AU2008332968A patent/AU2008332968B2/en not_active Ceased
- 2008-12-03 JP JP2010536523A patent/JP5501245B2/ja not_active Expired - Fee Related
- 2008-12-03 HR HRP20140344TT patent/HRP20140344T4/hr unknown
- 2008-12-03 PL PL08855772T patent/PL2227488T6/pl unknown
- 2008-12-03 CA CA2707559A patent/CA2707559C/en active Active
- 2008-12-03 CN CN200880119313.1A patent/CN101889024B/zh not_active Expired - Fee Related
- 2008-12-03 MY MYPI20102567 patent/MY150995A/en unknown
- 2008-12-03 PT PT88557723T patent/PT2227488E/pt unknown
- 2008-12-03 WO PCT/GB2008/003996 patent/WO2009071886A1/en not_active Ceased
- 2008-12-03 EP EP08855772.3A patent/EP2227488B3/en active Active
- 2008-12-03 KR KR1020107011743A patent/KR101519840B1/ko not_active Expired - Fee Related
- 2008-12-03 NZ NZ585217A patent/NZ585217A/xx not_active IP Right Cessation
- 2008-12-03 BR BRPI0820143 patent/BRPI0820143A2/pt not_active Application Discontinuation
- 2008-12-03 EA EA201070681A patent/EA019370B1/ru not_active IP Right Cessation
- 2008-12-03 MX MX2010006084A patent/MX2010006084A/es active IP Right Grant
- 2008-12-03 DK DK08855772.3T patent/DK2227488T6/en active
- 2008-12-03 CA CA3005013A patent/CA3005013C/en active Active
-
2010
- 2010-04-29 ZA ZA2010/02997A patent/ZA201002997B/en unknown
- 2010-05-13 IL IL205780A patent/IL205780A/en active IP Right Grant
- 2010-07-02 EC EC2010010327A patent/ECSP10010327A/es unknown
-
2014
- 2014-02-10 JP JP2014023217A patent/JP6063402B2/ja not_active Expired - Fee Related
- 2014-04-15 CY CY20141100281T patent/CY1115168T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ585217A (en) | Fviii peptides and their use in tolerising haemophiliacs | |
| EA201592264A1 (ru) | Композиции, которые индуцируют хелперное действие т-клеток | |
| EP2400021A3 (en) | ErbB3 based methods and compositions for treating neoplasms | |
| UA103751C2 (ru) | Иммуногенный пептид для иммунотерапии | |
| NZ595707A (en) | Cancer antigen helper peptide | |
| EA201070271A1 (ru) | Пептиды для получения вакцины | |
| WO2008121615A3 (en) | Antibody formulation | |
| IN2012DN03338A (cg-RX-API-DMAC7.html) | ||
| PH12016500218A1 (en) | Peptides | |
| ATE412671T1 (de) | Modifizierter faktor viii | |
| MY168207A (en) | Fviii-derived peptides | |
| PH12015501033A1 (en) | Peptides | |
| IL184609A0 (en) | Compositions containing an antigen and an adjuvent peptide | |
| EA201171001A1 (ru) | Пептиды трав для вакцины | |
| UA97092C2 (ru) | T-клеточные эпитопы с раково-эмбрионального антиген-незрелого рецепторного белка ламинина и их медицинское применение | |
| DE602005012686D1 (de) | Zusammensetzungen aus demethylierenden mitteln als verstärker der immuntherapie zur behanldung von cngen und behandlungsverfahren dafür | |
| ZA200707970B (en) | Compositions of HSP60 peptides and viral antigens for vaccination and diagnosis | |
| NZ605799A (en) | Wdrpuh epitope peptides and vaccines containing the same | |
| WO2008150981A3 (en) | Novel short peptides that inhibit the opening of mammalian tight junctions | |
| EA200970834A1 (ru) | Антитела к вирусу краснухи | |
| WO2007071850A3 (fr) | Inhibition de la réponse immunitaire anti-fviii | |
| WO2007097828A3 (en) | Method for identifying and validating dominant t helper cell epitopes using an hla-dm-assisted class ii binding assay | |
| TH130487A (th) | เพปไทด์ที่อนุพัทธ์มาจากแฟคเตอร์ viii | |
| NZ601354A (en) | Peptide adjuvants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ASS | Change of ownership |
Owner name: APITOPE INTERNATIONAL NV, BE Free format text: OLD OWNER(S): APITOPE TECHNOLOGY (BRISTOL) LIMITED |
|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 03 DEC 2015 BY AJ PARK Effective date: 20130627 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 DEC 2016 BY CPA GLOBAL Effective date: 20151030 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 DEC 2017 BY CPA GLOBAL Effective date: 20161108 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 DEC 2018 BY CPA GLOBAL Effective date: 20171102 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 DEC 2019 BY CPA GLOBAL Effective date: 20181108 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 DEC 2020 BY RENEWALS TEAM Effective date: 20191127 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 DEC 2021 BY ENVOY Effective date: 20210601 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 DEC 2022 BY RENEWALS TEAM Effective date: 20211202 |
|
| ASS | Change of ownership |
Owner name: WORG PHARMACEUTICALS (HANGZHOU) CO., LTD., CN Effective date: 20220303 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 DEC 2023 BY AJ PARK Effective date: 20221208 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 DEC 2024 BY DENNEMEYER + CO. S.A R.L. Effective date: 20231123 |
|
| LAPS | Patent lapsed |